Table I.
Cytokines | Peritoneal Cavity (ng/ml)
|
|||
---|---|---|---|---|
6 h
|
24 h
|
|||
Live-P | Die-P | Live-P | Die-P | |
Proinflammatory | ||||
IL-1β | 2.0 ± 0.4 | 2.5 ± 0.3b | 1.7 ± 0.2 | 2.2 ± 0.2 |
IL-2 | 0.25 ± 0.06 | 0.28 ± 0.04 | 0.66 ± 0.1a,c | 0.45 ± 0.09 |
IL-6 | 98.2 ± 42.3a | 250.9 ± 79.2 | 5.8 ± 0.7a | 47.2 ± 11.6a |
IL-12 | 0.8 ± 0.1 | 1.1 ± 0.1b | 0.6 ± 0.1 | 0.9 ± 0.1b |
IL-17 | 0.44 ± 0.08a | 0.72 ± 0.11 | 0.29 ± 0.03a | 0.37 ± 0.03a |
IFN-γ | 1.4 ± 0.2 | 1.8 ± 0.4 | 0.9 ± 0.1 | 3.4 ± 1.7b |
CCL3 (MIP-1α) | 11.1 ± 1.9 | 16.2 ± 1.9 | 9.2 ± 1.3 | 43.8 ± 14.4a−c |
CCL2 (MCP-1) | 60.8 ± 16.4a | 119.8 ± 27.8 | 22.0 ± 2.9a | 17.0 ± 3.8a |
TNF-α | 0.15 ± 0.03 | 0.26 ± 0.03b,c | 0.11 ± 0.01 | 0.24 ± 0.03b,c |
ICAM-1 | 6.5 ± 1.2 | 9.1 ± 1.4 | 7.0 ± 0.7 | 8.8 ± 0.9 |
Anti-inflammatory | ||||
IL-1ra | 19.0 ± 3.2 | 22.5 ± 3.1 | 8.2 ± 0.8a,c | 13.6 ± 1.6b,c |
IL-4 | 1.6 ± 0.4 | 2.4 ± 0.4c | 0.6 ± 0.1a,c | 0.8 ± 0.1a,c |
IL-10 | 7.5 ± 1.2 | 17.7 ± 3.2b,c | 3.1 ± 0.8 | 16.0 ± 2.8b,c |
TNF-srI | 3.9 ± 0.7 | 6.0 ± 0.8b,c | 3.3 ± 0.3 | 5.6 ± 0.5b,c |
TNF-srII | 27.0 ± 4.8 | 33.5 ± 4.4 | 16.0 ± 1.6a,c | 20.6 ± 2.0a |
Concentrations were calculated as described in Materials and Methods (at 6 h n = 9 for Live-P and 11 for Die-P; at 24 h n = 24 for Live-P and 13 for Die-P). Results are shown as mean ± SEM.
p < 0.05 when compared with Die-P at 6 h.
p < 0.05 when compared with Live-P at 24 h.
p < 0.05 when compared with Live-P at 6 h.